What is Gallium-68 DOTA Peptide PET Imaging?

Gallium-68 DOTA Peptide PET imaging is a highly advanced nuclear medicine scan. It works by introducing a very small amount of a radioactive tracer into the body, which seeks out and attaches to neuroendocrine tumour cells. The PET scanner then captures detailed images, highlighting where these cells are located – even when tumours are very small or have spread to other parts of the body.

This level of detail gives clinicians a much clearer picture when making decisions about diagnosis and treatment and can be critical in planning the most effective care pathway for each patient.

A Significant Step Forward for South Australian Patients

Until now, access to neuroendocrine PET imaging in South Australia has been limited, largely due to the availability of the specialised tracer required to perform the scan. Recent advances in radiopharmaceutical supply, combined with continued investment in Gallium-68 PET capability at Jones Radiology, have made it possible to now offer this service.

For patients who have previously faced long waits for this type of imaging, this is a meaningful change – one that can make a real difference at what is often a stressful and uncertain time.

Where is it Available?

Gallium-68 DOTA Peptide PET imaging is now available at our Kurralta Park (Tennyson Centre) clinic. Our team at this location is fully equipped and ready to support patients and their referring clinicians through this process.

How to Access This Service:

This scan requires a referral from your treating specialist. If you or someone you care for has been diagnosed with, or is being investigated for, a neuroendocrine tumour, speak to your specialist about whether Gallium-68 DOTA Peptide PET imaging may be appropriate.

For referring clinicians, our team is available to assist with any questions about the service, clinical indications, and booking processes.

Please call us on 1800 375 663 for more information or to book your next scan.